Surgery Websites
Lobular Breast Cancer Research Program »  People »  Principal Investigator »  Rita Mukhtar, M.D.
Rita Mukhtar, M.D.

Rita Mukhtar, M.D.

  • Associate Professor of Surgery
  • Division of Surgical Oncology
  • Lobular Breast Cancer Research Program

Contact Information

Open Popup

1996-2000 University of California, Berkeley, AB Molecular and Cell Biology

2001-2006 University of California, San Francisco, MD

  • 2006-2012 University of California, San Francisco, Resident, General Surgery
  • 2012-2013 University of California, San Francisco, Chief Resident, General Surgery
  • 2009-2011 University of California, San Francisco, Post-doctoral Research Fellow
  • 2013-2014 University of California, San Francisco, Society of Surgical Oncology Fellow, Breast Surgery
  • 2009-2010 UCSF CTSI Advanced Training in Clinical Research
  • American Board of Surgery, General Surgery
  • Carol Franc Buck Breast Care Center
  • Axillary dissection
  • Breast Surgery
  • Emergency General Surgery
  • Lumpectomy
  • Nipple sparing/total skin sparing mastectomy
  • Seed and wire localization surgery
  • Sentinel lymph node biopsy

Breast oncologic surgeon-scientist Rita Mukhtar, M.D., Associate Professor of Surgery at UCSF, leads clinical and translational research on invasive lobular carcinoma (ILC), the second most common type of breast cancer, and an understudied disease with unique treatment challenges. Funded by the American Cancer Society and the Helen Diller Comprehensive Cancer Center, Dr. Mukhtar studies surgical outcomes and treatment response predictors in ILC. Additionally, she is the UCSF Principle Investigator for a surgical window trial testing pre-operative endocrine therapy in ILC. Dr. Mukhtar collaborates with a multidisciplinary team from The Helen Diller Family Comprehensive Cancer Center to advance ILC research and innovate targeted treatment strategies that improve patient lives and outcomes.

Dr Mukhtar completed her undergraduate education at UC Berkeley, where she studied music and molecular biology. She then attended medical school at UCSF, during which time she received a Doris Duke Clinical Research Fellowship and pursued research in the inflammatory response in sepsis, winning a resident research award. She remained at UCSF for General Surgery residency, and completed a two year post-doctoral research fellowship focusing on the role of inflammatory cells in breast cancer outcomes, funded by the California Breast Cancer Research Program.

During this time she received a scholarship from the UCSF Clinical and Translational Science Institute to complete a certificate in Advanced Training in Clinical Research. After residency, she completed a fellowship in breast oncologic surgery. She currently practices breast surgery, including treatment of benign and malignant breast disease, and acute care general surgery.

Data provided by UCSF Profiles, powered by CTSI
MOST RECENT PUBLICATIONS FROM A TOTAL OF 72
Data provided by UCSF Profiles, powered by CTSI
  1. Abel MK, Shui AM, Chien AJ, Rugo HS, Melisko M, Baehner F, Mukhtar RA. The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study. Ann Surg Oncol. 2022 Jul 09. View in PubMed
  2. Abel MK, Mukhtar RA. ASO Author Reflections: Discordant Clinical and Molecular Risk in Invasive Lobular Carcinoma of the Breast: The 21-Gene Recurrence Score in the National Cancer Database by Histologic Subtype. Ann Surg Oncol. 2022 Jul 07. View in PubMed
  3. Abel MK, Shui AM, Chien AJ, Rugo HS, Melisko M, Baehner F, Mukhtar RA. ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study. Ann Surg Oncol. 2022 Jul 07. View in PubMed
  4. Greenberg AL, Sullins VF, Donahue TR, Sundaram VM, Saldinger PF, Divino CM, Anton NE, Stefanidis D, Reilly LM, Egan RJ, Beals CKJ, Riall TS, Duh QY, Mukhtar RA, Hirose K, Lebares CC. Emotional Regulation in Surgery: Fostering Well-Being, Performance, and Leadership. J Surg Res. 2022 Sep; 277:A25-A35. View in PubMed
  5. Mukhtar R, Symmans WF, Esserman LJ. Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer-Reply. JAMA Oncol. 2022 04 01; 8(4):1. View in PubMed
  6. View All Publications

 

Site Directory
    X